NFKB1 and breast carcinoma: Thus, these findings underscore the need to further investigate combining inhibitors of Notch1 and NF-κB with chemotherapy to decrease chemotherapy-induced cancer cell dissemination and prolong survival of patients with advanced breast cancer.